Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial-Reference-Cited by-同舟云学术

Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial

Published:2019-12 Issue:12 Volume:20 Page:1740-1749
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Carrie Christian,Magné Nicolas,Burban-Provost Patricia,Sargos Paul,Latorzeff Igor,Lagrange Jean-Léon,Supiot Stéphane,Belkacemi Yazid,Peiffert Didier,Allouache Nedla,Dubray Bernard M,Servagi-Vernat Stéphanie,Suchaud Jean-Philippe,Crehange Gilles,Guerif Stéphane,Brihoum Meryem,Barbier Nicolas,Graff-Cailleaud Pierre,Ruffion Alain,Dussart Sophie,Ferlay Céline,Chabaud Sylvie

Funder

French Health Ministry

Publisher

Elsevier BV

Subject

Oncology

Reference32 articles.

1. Radiation therapy after radical prostatectomy: impact on metastasis and survival;Boorjian;J Urol,2009

2. Salvage radiation therapy for biochemical failure following radical prostatectomy;Spieler;Isr Med Assoc J,2017

3. Improved metastasis-free and survival outcomes with early salvage radiotherapy in men with detectable prostate-specific antigen after prostatectomy for prostate cancer;Stish;J Clin Oncol,2016

4. Natural history of progression after PSA elevation following radical prostatectomy;Pound;JAMA,1999

5. The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up;Antonarakis;BJU Int,2012

Cited by 177 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Undetectable PSA predicts outcome after salvage radiotherapy for biochemical recurrence following radical prostatectomy;Radiotherapy and Oncology;2024-11

2. Salvage therapies for biochemical recurrence after definitive local treatment: a systematic review, meta-analysis, and network meta-analysis;Prostate Cancer and Prostatic Diseases;2024-09-13

3. Prognostic factors in post-prostatectomy salvage radiotherapy setting with and without hormonotherapy: An individual patient data analysis of randomized trials from ICECaP database;Radiotherapy and Oncology;2024-09

4. PROshot: Immunotherapy for Cervical Cancer, Epidermal Growth Factor Receptor-Mutated Stage III Lung Cancer, Perioperative Chemotherapy for Esophageal Cancer, Salvage Postprostatectomy Radiation and Androgen Deprivation Therapy, and Immunotherapy for Head and Neck Cancer;Practical Radiation Oncology;2024-09

5. Further Randomized Data Confirming Minimal Benefit from the Addition of Hormone Therapy to Postoperative Radiotherapy;European Urology;2024-09